One Plus One Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
One Plus One Wealth Management's BMY Position: Q3 2021 in Review
One Plus One Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 3,216 shares — an estimated $215K sold.
One Plus One Wealth Management first reported a position in BMY in Q2 2021 and held it in 1 quarter. The position peaked at $215K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- One Plus One Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
- One Plus One Wealth Management sold 3,216 Bristol-Myers Squibb shares in Q3 2021, an estimated $215K.
- One Plus One Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 1 quarter.
- One Plus One Wealth Management's Bristol-Myers Squibb position peaked at $215K in Q2 2021.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on One Plus One Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.